20 June 2013
Keywords: actelion, unveils, new, pipeline, targets, first, day
Article | 10 June 2002
Extending the indications for Tracleer (bosentan) and developing Veletri(tezosentan) for acute heart failure are the two key near-term
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
10 June 2002
19 June 2013
© 2013 thepharmaletter.com